* Celgene Corp., of Warren, N.J. has begun a randomized, double-blind, placebo-controlled Phase II trial of thalidomide for cachexia,or wasting, in advanced AIDS patients. Celgene licensed athalidomide use patent filed by The Rockefeller University of NewYork.* Advanced Magnetics Inc., of Cambridge, Mass., said theEuropean Union's Committee for Proprietary and MedicinalProducts recommended approval of Endorem, the company'sinjectable liver contrast agent.* Gliatech Inc., of Cleveland, was awarded a $75,000 SmallBusiness Innovation Research grant for research aimed atdeveloping products to inhibit formation of adhesions followingtendon surgery.* Quadra Logic Technologies Inc., of Vancouver, British Columbia,said results from 17 patients with mild to moderate psoriasisshowed that photodynamic therapy with Benzoporphyrin derivativeshould be pursued as a treatment.

(c) 1997 American Health Consultants. All rights reserved.